Table of Contents

July 01, 1987; Volume 32,Issue 1

You have access
Structural characteristics of the 35- and 36-kDa forms of the beta subunit common to GTP-binding regulatory proteins.
M J Woolkalis and D R Manning

Molecular Pharmacology July 1987, 32 (1) 1-6;
You have access
Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka

Molecular Pharmacology July 1987, 32 (1) 7-12;
You have access
Effects of cis- and trans-tamoxifen isomers on RNA incorporation of human breast cancer cells.
C Benz and G F Santos

Molecular Pharmacology July 1987, 32 (1) 13-16;
You have access
Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke

Molecular Pharmacology July 1987, 32 (1) 17-25;
You have access
Interactions between adenosine and alpha 1-adrenergic agonists in regulation of respiration in hamster brown adipocytes.
R J Schimmel, M E Elliott and V C Dehmel

Molecular Pharmacology July 1987, 32 (1) 26-33;
You have access
Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
N Aiyar, P Nambi, F Stassen and S T Crooke

Molecular Pharmacology July 1987, 32 (1) 34-36;
You have access
Phorbol ester-stimulated bidirectional transmembrane calcium flux in A7r5 vascular smooth muscle cells.
G Sperti and W S Colucci

Molecular Pharmacology July 1987, 32 (1) 37-42;
You have access
The relationship between alpha 1-adrenergic receptor occupancy and response in BC3H-1 muscle cells.
R D Brown, K D Berger and P Taylor

Molecular Pharmacology July 1987, 32 (1) 43-52;
You have access
Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel

Molecular Pharmacology July 1987, 32 (1) 53-58;
You have access
Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
K M MacLeod, D D Ng, K H Harris and J Diamond

Molecular Pharmacology July 1987, 32 (1) 59-64;
You have access
Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
A Convents, J P De Backer, D Convents and G Vauquelin

Molecular Pharmacology July 1987, 32 (1) 65-72;
You have access
Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes.
S K Yang and Z P Bao

Molecular Pharmacology July 1987, 32 (1) 73-80;
You have access
Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
S K Fisher and R M Snider

Molecular Pharmacology July 1987, 32 (1) 81-90;
You have access
Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
M Waelbroeck, M Gillard, P Robberecht and J Christophe

Molecular Pharmacology July 1987, 32 (1) 91-99;
You have access
Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
M Gillard, M Waelbroeck and J Christophe

Molecular Pharmacology July 1987, 32 (1) 100-108;
You have access
Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
S M Kazmi and R K Mishra

Molecular Pharmacology July 1987, 32 (1) 109-118;
You have access
Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
B A Dodson, L M Braswell and K W Miller

Molecular Pharmacology July 1987, 32 (1) 119-126;
You have access
Calmodulin may play a pivotal role in neurotransmitter-mediated inhibition and stimulation of rat cerebellar adenylate cyclase.
M K Ahlijanian and D M Cooper

Molecular Pharmacology July 1987, 32 (1) 127-132;
You have access
Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon

Molecular Pharmacology July 1987, 32 (1) 133-139;
You have access
Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
T Nakajima and A Katoh

Molecular Pharmacology July 1987, 32 (1) 140-146;
You have access
Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
R T Coughlin, T Akera, E J McGroarty and C Steinbach

Molecular Pharmacology July 1987, 32 (1) 147-153;
You have access
Treatment with dilute alkali-nuclease S1 permits the analysis of DNA damage: cells treated with platinum analogues.
U Lönn and S Lönn

Molecular Pharmacology July 1987, 32 (1) 154-161;
You have access
The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns

Molecular Pharmacology July 1987, 32 (1) 162-167;
You have access
alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster

Molecular Pharmacology July 1987, 32 (1) 169-172;
You have access
Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock

Molecular Pharmacology July 1987, 32 (1) 173-177;
You have access
Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product.
C D Strader, M R Candelore, E Rands and R A Dixon

Molecular Pharmacology August 1987, 32 (1) 179-183;
You have access
A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.
G L Stiles and K A Jacobson

Molecular Pharmacology August 1987, 32 (1) 184-188;
You have access
Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett

Molecular Pharmacology August 1987, 32 (1) 189-194;
You have access
Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke

Molecular Pharmacology August 1987, 32 (1) 195-200;
You have access
Relative abundance of two molecular forms of Na+,K+-ATPase in the ferret heart: developmental changes and associated alterations of digitalis sensitivity.
Y C Ng and T Akera

Molecular Pharmacology August 1987, 32 (1) 201-205;
You have access
Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
M Kelley, P Hantelle, S Safe, W Levin and P E Thomas

Molecular Pharmacology August 1987, 32 (1) 206-211;
You have access
Calmodulin stimulation of the rat cerebral cortical adenylate cyclase is required for the detection of guanine nucleotide- or hormone-mediated inhibition.
E Perez-Reyes and D M Cooper

Molecular Pharmacology August 1987, 32 (1) 212-216;
You have access
Effect of ethanol on mouse cerebral cortical beta-adrenergic receptors.
P Valverius, P L Hoffman and B Tabakoff

Molecular Pharmacology August 1987, 32 (1) 217-222;
You have access
SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke

Molecular Pharmacology August 1987, 32 (1) 223-229;
You have access
Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston

Molecular Pharmacology August 1987, 32 (1) 230-240;
You have access
Alpha 2-adrenoceptor stimulation affects total glucose utilization in isolated islets of Langerhans.
S G Laychock

Molecular Pharmacology August 1987, 32 (1) 241-248;
You have access
Heterologous regulations of cAMP responses in pregnant rat myometrium. Evolution from a stimulatory to an inhibitory prostaglandin E2 and prostacyclin effect.
Z Tanfin and S Harbon

Molecular Pharmacology August 1987, 32 (1) 249-257;
You have access
Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
R M McKernan, M J Howard, H J Motulsky and P A Insel

Molecular Pharmacology August 1987, 32 (1) 258-265;
You have access
gamma-Aminobutyric acid receptor binding in fresh mouse brain membranes at 22 degrees C: ligand-induced changes in affinity.
J S Yang and R W Olsen

Molecular Pharmacology August 1987, 32 (1) 266-277;
You have access
Voltage-dependent nitrendipine binding to cardiac sarcolemmal vesicles.
T J Kamp and R J Miller

Molecular Pharmacology August 1987, 32 (1) 278-285;
You have access
Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
E De Clercq, J Bères and W G Bentrude

Molecular Pharmacology August 1987, 32 (1) 286-292;
You have access
Mechanism of transport for toxic cysteine conjugates in rat kidney cortex membrane vesicles.
V H Schaeffer and J L Stevens

Molecular Pharmacology August 1987, 32 (1) 293-298;
You have access
Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia

Molecular Pharmacology August 1987, 32 (1) 299-308;
You have access
The role of formate and S-adenosylmethionine in the reversal of nitrous oxide inhibition of formate oxidation in the rat.
A B Makar and T R Tephly

Molecular Pharmacology August 1987, 32 (1) 309-314;
You have access
Effect of beta-naphthoflavone on mitochondrial supply of reducing equivalents for monooxygenation in periportal and pericentral regions of the liver lobule.
S A Belinsky, F W Kari, F C Kauffman and R G Thurman

Molecular Pharmacology August 1987, 32 (1) 315-320;